Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Francois Nader files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Stephane Bancel - $28.72M in MRNA purchases and sales in the last 12 months
- Stephen Hoge - $28.43M in MRNA purchases and sales in the last 12 months
- James M. Mock - $4.69M in MRNA purchases and sales in the last 12 months
- Shannon Thyme Klinger - $1.39M in MRNA purchases and sales in the last 12 months
- Noubar Afeyan - $434K in MRNA purchases and sales in the last 12 months
- Marcella K. Ruddy - $363K in TECX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Francois Nader?
Francois Nader is a corporate insider, tracked as Director of Moderna, Inc. (MRNA). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Francois Nader last file a Form 4?
The most recent primary Form 4 on record is dated 8 May 2026, one of 3 filings going back to 2026.
